-+ 0.00%
-+ 0.00%
-+ 0.00%

IN8BIO REPORTS CONTINUED PROGRESSION-FREE SURVIVAL IN PHASE 1 INVESTIGATOR-SPONSORED TRIAL OF INB-100 ALLOGENEIC GAMMA-DELTA T CELLS FOR LEUKEMIAS AT THE 2024 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING

Reuters·12/10/2024 12:00:01

Please log in to view news